279 related articles for article (PubMed ID: 8476069)
41. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency.
Hill AT; Bayley DL; Campbell EJ; Hill SL; Stockley RA
Eur Respir J; 2000 May; 15(5):886-90. PubMed ID: 10853853
[TBL] [Abstract][Full Text] [Related]
42. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis.
Lin HC; Cheng HF; Wang CH; Liu CY; Yu CT; Kuo HP
Am J Respir Crit Care Med; 1997 Jun; 155(6):2024-9. PubMed ID: 9196111
[TBL] [Abstract][Full Text] [Related]
43. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Shibuya Y; Wills PJ; Cole PJ
Respiration; 2001; 68(6):615-9. PubMed ID: 11786718
[TBL] [Abstract][Full Text] [Related]
44. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis.
Stites SW; Walters B; O'Brien-Ladner AR; Bailey K; Wesselius LJ
Chest; 1998 Sep; 114(3):814-9. PubMed ID: 9743172
[TBL] [Abstract][Full Text] [Related]
45. Sputum trace metals are biomarkers of inflammatory and suppurative lung disease.
Gray RD; Duncan A; Noble D; Imrie M; O'Reilly DS; Innes JA; Porteous DJ; Greening AP; Boyd AC
Chest; 2010 Mar; 137(3):635-41. PubMed ID: 19801580
[TBL] [Abstract][Full Text] [Related]
46. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
47. Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis.
Sastre B; Fernández-Nieto M; Mollá R; López E; Lahoz C; Sastre J; del Pozo V; Quirce S
Allergy; 2008 Jan; 63(1):58-66. PubMed ID: 17961198
[TBL] [Abstract][Full Text] [Related]
48. Interleukin 8 in the tracheobronchial aspirate of infants acts as a neutrophil chemotactic factor in the development of chronic lung disease.
Takasaki J; Ogawa Y
Pediatr Int; 1999 Feb; 41(1):78-81. PubMed ID: 10200141
[TBL] [Abstract][Full Text] [Related]
49. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation.
Downey DG; Brockbank S; Martin SL; Ennis M; Elborn JS
Pediatr Pulmonol; 2007 Aug; 42(8):729-35. PubMed ID: 17588254
[TBL] [Abstract][Full Text] [Related]
50. Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis.
Shum DK; Chan SC; Ip MS
Am J Respir Crit Care Med; 2000 Nov; 162(5):1925-31. PubMed ID: 11069836
[TBL] [Abstract][Full Text] [Related]
51. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases.
Fahy JV; Schuster A; Ueki I; Boushey HA; Nadel JA
Am Rev Respir Dis; 1992 Dec; 146(6):1430-3. PubMed ID: 1280928
[TBL] [Abstract][Full Text] [Related]
52. Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: green is not good.
Meyer KC
J Lab Clin Med; 2004 Sep; 144(3):124-6. PubMed ID: 15478278
[No Abstract] [Full Text] [Related]
53. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis.
Tamaoki J; Chiyotani A; Kobayashi K; Sakai N; Kanemura T; Takizawa T
Am Rev Respir Dis; 1992 Mar; 145(3):548-52. PubMed ID: 1546834
[TBL] [Abstract][Full Text] [Related]
54. Chemotactic factors in bronchial secretions of cystic fibrosis patients.
Dayer Pastore F; Schlegel-Haueter SE; Belli DC; Rochat T; Dudez TS; Suter S
J Infect Dis; 1998 May; 177(5):1413-7. PubMed ID: 9593037
[TBL] [Abstract][Full Text] [Related]
55. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
56. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis.
Dakin CJ; Pereira JK; Henry RL; Wang H; Morton JR
Pediatr Pulmonol; 2002 Jun; 33(6):475-82. PubMed ID: 12001282
[TBL] [Abstract][Full Text] [Related]
57. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
Lethem MI; James SL; Marriott C
Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
[TBL] [Abstract][Full Text] [Related]
58. [Functional activity of the neutrophils in the bronchoalveolar space in chronic bronchitis and bronchiectasis].
Grobova OM; Kop'eva TN; Dykhanov II; Rusakov MA
Lab Delo; 1991; (4):31-5. PubMed ID: 1715428
[TBL] [Abstract][Full Text] [Related]
59. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.
Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE
J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881
[TBL] [Abstract][Full Text] [Related]
60. Sputum leukotrienes in obstructive airways diseases.
O'Driscoll BR; Cromwell O; Kay AB
Clin Exp Immunol; 1984 Feb; 55(2):397-404. PubMed ID: 6321071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
